LONDON, Jan. 27, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce a new publication showing that its PICO Single Use Negative ...
The Food & Drug Administration has approved Smith & Nephew’s PICO wound care system, the company announced. The pocket-sized Negative Pressure Wound Therapy (NPWT) system is indicated for pressure and ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) ...
Smith & Nephew plc added new indications for use of its Pico 7 and Pico 14 single-use negative pressure wound therapy (sNPWT) systems. The FDA cleared the London-based device maker’s systems for ...
The clearance was based on data from 25 clinical studies which included 5560 patients. The Food and Drug Administration (FDA) has cleared Smith+Nephew’s PICO 7 and PICO 14 Single Use Negative Pressure ...
LONDON , Jan. 27, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce a new publication showing that its PICO Single Use Negative ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback